The co-ordinators took turns to chair teleconferences, led discussions on specific issues at AGM discussion sessions, at joint workshops with other work-packages such as WP1 (quality issues), WP3 (toxicology issues) and WP6 (clinical trial issues). The task force involved coordinators, academics who are actively involved with R&D of Chinese herbal medicines, experts on monographic standards of Chinese materia medica, representatives from regulatory agencies, experts from industries in marketing Chinese medicines/ herbal medicines and natural products. A collaborative network task force was established during the early stage of the GP-TCM project and operated through exchanges, teleconferences and focused discussions at annual meetings. ![]() Case studies are also presented to illustrate the problems involved in registering TCM products in different regions worldwide. The paper aims to collate data and draw comparison of these regulations. One of the key deliverables of the Work Package 7 in GP-TCM was to investigate information of the existing requirements for registration of TCM products listed by global regulatory bodies. GP-TCM is the first EU-funded Coordination Action consortium dedicated to traditional Chinese medicine (TCM) research. ![]() ![]() Future development of global regulations of Chinese herbal products.įan, Tai-Ping Deal, Greer Koo, Hoi-Lun Rees, Daryl Sun, He Chen, Shaw Dou, Jin-Hui Makarov, Valery G Pozharitskaya, Olga N Shikov, Alexander N Kim, Yeong Shik Huang, Yi-Tsau Chang, Yuan Shiun Jia, William Dias, Alberto Wong, Vivian Chi-Woon Chan, Kelvin
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |